Actively Recruiting
Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.
Led by Novartis Pharmaceuticals · Updated on 2026-02-23
70
Participants Needed
2
Research Sites
91 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an observational study to evaluate the effectiveness and safety of secukinumab in participants with AS who have never used TNFi, JAKi, or IL-17i drugs before.
CONDITIONS
Official Title
Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with ankylosing spondylitis according to the modified 1984 New York criteria
- Active disease symptoms with a BASDAI score of 4 or higher at screening and baseline
- Never used TNFi, JAKi, or IL-17i drugs before
- Suitable for secukinumab treatment as approved by the Ministry of Food and Drug Safety
- Diagnosis of AS made less than 5 years ago
- Aged between 18 and 40 years
- Provided informed consent to participate in the study
You will not qualify if you...
- Medical or psychological conditions preventing participation during the 28±4 week study period
- Presence of congenital or traumatic spinal deformities
- Currently enrolled in other clinical studies
- Any contraindications to secukinumab treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Novartis Investigative Site
Jinju, Gyeongsangnam-do, South Korea, 52727
Actively Recruiting
2
Novartis Investigative Site
Busan, South Korea, 49201
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals, MD
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here